Physician profile
Patrick J Harris
NPI 1063525350
$1,502.30
in general payments reported to CMS, 2019-2025
20 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2020: $212 · 2021: $106 · 2022: $75.77 · 2023: $82.49 · 2024: $162 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $441.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $563.31 | 2019-2025 | Wegovy |
| Lilly USA, LLC | $134.74 | 2019-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $119.79 | 2023-2025 | Trelegy Ellipta, Rotarix, Pediarix |
| Amarin Pharma, INC. | $108.73 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $88.66 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $75.69 | 2022-2024 | Airsupra, Breztri |
| Janssen Pharmaceuticals, INC | $72.95 | 2019-2025 | Spravato |
| Abbvie INC. | $63.34 | 2021-2025 | |
| Astellas Pharma US INC | $51.58 | 2024-2025 | Veozah |
| Allergan, INC. | $33.92 | 2019 | |
| Exact Sciences Corporation | $33.66 | 2024-2025 | Cologuard Collection Kit |
| Kvk-Tech, INC. | $21.88 | 2019 | |
| Eisai INC. | $21.50 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $18.03 | 2020 | |
| Merck Sharp & Dohme LLC | $17.43 | 2025 | Capvaxive, Gardasil 9 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.54 | 2023 | |
| Hikma Pharmaceuticals USA | $16.32 | 2024 | Kloxxado, Ryaltris |
| Bayer Healthcare Pharmaceuticals INC. | $15.30 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.57 | 2020 | |
| Amgen INC. | $14.36 | 2025 | Otezla, Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.